17-72124177-C-G
Variant summary
Our verdict is Pathogenic. The variant received 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_000346.4(SOX9):c.1320C>G(p.Tyr440*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. Y440Y) has been classified as Likely benign.
Frequency
Consequence
NM_000346.4 stop_gained
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 14 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 37
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:3
Nonsense variant predicted to result in protein truncation, as the last 70 amino acids are lost, and other loss-of-function variants have been reported downstream in HGMD; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 27065010, 9002675, 15806394, 36343245, 36584300, 34627339, 8001137) -
- -
The SOX9 c.1320C>G; p.Tyr440Ter variant (rs80338688) is reported in the literature in individuals affected with campomelic dysplasia or suspected skeletal dysplasia (Hageman 1998, Meyer 1997, Pop 2005, Scocchia 2021), including an apparently de novo variant in one individual (Wagner 1994). This variant is also reported in ClinVar (Variation ID: 2510). This variant is absent from the Genome Aggregation Database (v2.1.1), indicating it is not a common polymorphism. Additionally, another variant at this nucleotide resulting in the same premature termination codon (c.1320C>A; p.Tyr440Ter) has been reported in individuals with campomelic dysplasia and is considered pathogenic (Pop 2005). Functional analyses of the variant protein demonstrate reduced but not eliminated transactivation activity (Au 2023, Pop 2005, Wagner 1994), suggesting this may be a hypomorphic variant with potential combined haploinsufficient and dominant-negative mechanisms. This variant results in a premature termination codon in the last exon of the SOX9 gene. While this may not lead to nonsense-mediated decay, it is expected to create a truncated protein. Based on available information, this variant is considered to be pathogenic. References: Au TYK et al. Hypomorphic and dominant-negative impact of truncated SOX9 dysregulates Hedgehog-Wnt signaling, causing campomelia. Proc Natl Acad Sci U S A. 2023 Jan 3;120(1):e2208623119. PMID: 36584300. Hageman RM et al. Mutation analysis of the SOX9 gene in a patient with campomelic dysplasia. Hum Mutat. 1998;Suppl 1:S112-3. PMID: 9452058. Meyer J et al. Mutational analysis of the SOX9 gene in campomelic dysplasia and autosomal sex reversal: lack of genotype/phenotype correlations. Hum Mol Genet. 1997 Jan;6(1):91-8. PMID: 9002675. Pop R et al. A homozygous nonsense mutation in SOX9 in the dominant disorder campomelic dysplasia: a case of mitotic gene conversion. Hum Genet. 2005 Jun;117(1):43-53. PMID: 15806394. Scocchia A et al. Diagnostic utility of next-generation sequencing-based panel testing in 543 patients with suspected skeletal dysplasia. Orphanet J Rare Dis. 2021 Oct 9;16(1):412. PMID: 34627339. Wagner T et al. Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell. 1994 Dec 16;79(6):1111-20. PMID: 8001137. -
CAMPOMELIC DYSPLASIA WITH AUTOSOMAL SEX REVERSAL Pathogenic:1
- -
Connective tissue disorder Pathogenic:1
- -
Camptomelic dysplasia Other:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at